# Acute Effect of Exenatide on Brain Glucose Metabolism

> **NCT01588418** · PHASE4 · COMPLETED · sponsor: **The University of Texas Health Science Center at San Antonio** · enrollment: 15 (actual)

## Conditions studied

- Impaired Glucose Tolerance (IGT)
- Diabetes

## Interventions

- **DRUG:** Exenatide
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT01588418
- **Lead sponsor:** The University of Texas Health Science Center at San Antonio
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-07
- **Primary completion:** 2015-07
- **Final completion:** 2015-07
- **Target enrollment:** 15 (ACTUAL)
- **Last updated:** 2017-11-24

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01588418

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01588418, "Acute Effect of Exenatide on Brain Glucose Metabolism". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT01588418. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*